Overcoming Medical Overuse with AI Assistance: An Experimental Investigation

Last registered on August 06, 2024

Pre-Trial

Trial Information

General Information

Title
Overcoming Medical Overuse with AI Assistance: An Experimental Investigation
RCT ID
AEARCTR-0014109
Initial registration date
July 31, 2024

Initial registration date is when the trial was registered.

It corresponds to when the registration was submitted to the Registry to be reviewed for publication.

First published
August 06, 2024, 1:24 PM EDT

First published corresponds to when the trial was first made public on the Registry after being reviewed.

Locations

Region

Primary Investigator

Affiliation
Wuhan University

Other Primary Investigator(s)

PI Affiliation
Wuhan University
PI Affiliation
Wuhan University

Additional Trial Information

Status
On going
Start date
2024-07-25
End date
2024-08-31
Secondary IDs
Prior work
This trial is based on or builds upon one or more prior RCTs.
Abstract
This study explores the potential of Artificial Intelligence (AI) in mitigating medical overuse, specifically analyzing physicians' decision-making processes in a controlled experimental environment. Medical overuse, defined as unnecessary interventions that may cause harm to patients and increase healthcare costs, is a significant problem in both developed and developing healthcare systems. By integrating AI tools that provide evidence-based recommendations, this study aims to understand the extent to which AI can influence physician behavior and reduce overtreatment.

This experimental design consists of a field experiment conducted within a hospital, and we used a two-by-three factorial design to manipulate monetary incentives and the availability of AI assistance between different groups of physicians. We built on previous experiments by conducting a field experiment using real physicians, excluding the effects of physician self-learning as well as ordinal effects, examining AI-assisted consultations as a between-subject variable, and exploring the effects of physicians' overuse rates and clinical decision-making accuracy in familiar and unfamiliar consultation scenarios. Key findings of the study include the frequency of overtreatment, diagnostic accuracy, and adoption of AI recommendations.

The findings are expected to provide a broader contribution based on previous research, providing policymakers and healthcare administrators with more nuanced insights about the value of integrating AI technology in healthcare settings to potentially improve healthcare efficiency and patient safety.
External Link(s)

Registration Citation

Citation
Wang, Ziyi, Lijia Wei and Lian Xue. 2024. "Overcoming Medical Overuse with AI Assistance: An Experimental Investigation." AEA RCT Registry. August 06. https://doi.org/10.1257/rct.14109-1.0
Experimental Details

Interventions

Intervention(s)
Intervention Start Date
2024-08-01
Intervention End Date
2024-08-30

Primary Outcomes

Primary Outcomes (end points)
The key outcome variables in this experiment are the degree of physician overtreatment, and AI on accuracy rate.
Primary Outcomes (explanation)

Secondary Outcomes

Secondary Outcomes (end points)
Secondary Outcomes (explanation)

Experimental Design

Experimental Design
We conducted a field experiment at the Central South Hospital, utilizing a two-by-three factorial design. The participants, referred to as physicians, were recruited from this institution.

Incentive Schemes (Between-Subject): The experiment varied the incentive structures for participants when making choices in a multiple-choice medicine prescription task. Three types of incentives were tested: flat, progressive, and regressive, affecting how participants were compensated for their choices.

AI Assistance (Between-Subject): The experiment was set up for participants with and without AI-assisted clinic recommendations as an incentive structure.

Control Variables: To account for individual fixed effects and other potential confounders affecting the propensity for overtreatment, we implemented pre- and post-experiment assessments. These assessments collected data on doctors’ professional abilities, algorithm literacy, trust in algorithms, awareness of algorithms, and perceptions of algorithm fairness.
Experimental Design Details
1.Medicine Prescription Task
In this experiment, the medical exam question bank was divided into 8 different specialty sections according to the introduction of diseases. Participants would first choose the specialty direction they specialize in for medical decision-making, in which there are 20 multiple choice questions; after that, the system would randomly match to the decision-making questions in the direction of another specialty department, and participants need to answer 20 questions. An example of such a question is provided below:
Female, 54 years old, with a history of hyperthyroidism. Recently, due to overwork and emotional stress, she has experienced insomnia, and heart and chest discomfort. Physical examination: Heart rate 160 beats per minute, electrocardiogram shows clear signs of myocardial ischemia, and sinus rhythm irregularity. The best choice would be:
Options:
A. Amiodarone
B. Quinidine
C. Procainamide
D. Propranolol
E. Lidocaine

2.Treatment Design
(1)Incentive Schemes (Between-Subject):
• Flat Treatment: Participants received a constant monetary payoff of 3 yuan for each task completed, regardless of their choice.
• Progressive Treatment: Participants received a higher payoff for selecting two options (4 yuan) versus one (2 yuan).
• Regressive Treatment: Participants received varied payoffs depending on the number of choices and accuracy of their answers: 4 yuan for one correct choice, 3 yuan for two choices including the correct answer, 1 yuan for one incorrect choice, and 0 yuan for two incorrect choices.
(2)AI Assistance (Between-Subject):
There were two groups in each treatment, one with no AI recommendations(with NOAI) and the other with AI recommendations(with
AI).AI assistance was presented as follows:
The AI recommends option: D.
Analysis: Based on the patient’s symptoms and physical examination results, the optimal medication choice is usually D. Propranolol. This beta-blocker is commonly used to control rapid heart rates and arrhythmias, particularly in hyperthyroidism cases. It helps slow down the heart rate, reduce the cardiac workload, and alleviate myocardial ischemia symptoms. However, a specific treatment plan should be consulted with a physician.

Therefore this experiment was divided into 6 treatments: Flat with NOAI; Flat with AI; Progressive with NOAI; Progressive with AI; Regressive with NOAI; Regressive with AI.

Additionally, depending on participants choices, we donate to a patients regarding charity with the following rules:16 yuan for one correct choice, 12 yuan for two choices including the correct answer, 4 yuan for one incorrect choice, and 0 yuan for two incorrect choices.
Randomization Method
randomization in recruitment
Randomization Unit
Individual
Was the treatment clustered?
No

Experiment Characteristics

Sample size: planned number of clusters
According to our experimental design, participants need to be randomized equally into 6 clusters.
Sample size: planned number of observations
We aim to recruit between 180 and 240 participants.
Sample size (or number of clusters) by treatment arms
Based on our previous medical student experiment, we did a power analysis using the mean and standard deviation of the overuse rates of participants in the Regressive group before and after utilizing the AI recommendations, we conducted efficacy analyses and estimated the required sample size to be 39 in order to compare the disparity between-subject for AI-assisted diagnosis recommendations. Therefore, we decided to recruit 30-40 participants in the 6 groups of this experiment. So the experiment was set up with a total of 6 clusters, with a cluster of roughly 30-40 participants.
Minimum detectable effect size for main outcomes (accounting for sample design and clustering)
IRB

Institutional Review Boards (IRBs)

IRB Name
Economics and Management School of Wuhan University
IRB Approval Date
2024-07-20
IRB Approval Number
EM240021

Post-Trial

Post Trial Information

Study Withdrawal

There is information in this trial unavailable to the public. Use the button below to request access.

Request Information

Intervention

Is the intervention completed?
No
Data Collection Complete
Data Publication

Data Publication

Is public data available?
No

Program Files

Program Files
Reports, Papers & Other Materials

Relevant Paper(s)

Reports & Other Materials